Explore Products

miR‐885‐5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma

  • AcceGen R&D Team
  • Dec 24, 2020
  • 35

You Might Also Like

AcceGen Scroll Top Button